Skip to content
Ships from Provo, Utah · We ship to CanadaAll Prices are in US DollarsFor Research Use Only. Not for Human Consumption.

Delayed BPC-157 in a Fistula Model: Preventing Stones Is Not Dissolving Them

An intervention started after a defect is established tests a different question from immediate postoperative prevention. This experiment used a delayed-start fistula model. Primary study

What the investigators reported

BPC-157 treatment began two weeks after surgically creating vesicovaginal fistulas in rats. The authors reported improved closure and leakage-related outcomes, favorable tissue findings, and absence of the later bladder-stone formation seen in controls. Primary report

Our appraisal: distinguish established defects from later complications

The fistula existed before treatment, but that does not mean every later complication was already present. An absence of subsequently observed stones should not be described as dissolution of established stones unless that separate sequence was actually demonstrated.

Closure and leakage resistance also need separate definitions. A larger volume sustained before leakage is a functional test under specified conditions, not necessarily a direct measure of normal bladder capacity or continence in daily life. The baseline and comparator behind any fold change must be checked carefully.

Delayed initiation adds useful information compared with immediate treatment. Nevertheless, two weeks in a surgical rat model cannot define effectiveness for every chronic human fistula, particularly when causes and tissue conditions differ.

The relationship between healing and stone formation also remains a causal question. If closure changes the local environment, fewer stones might be downstream of improved healing rather than a direct anti-stone action. Distinguishing these explanations requires an appropriate design.

This report supports a model-specific delayed-treatment hypothesis. It does not establish a nonsurgical cure for human fistulas or a treatment for urinary stones. Full review should reconcile the leakage-volume wording with the underlying measurements, verify assessment masking, and examine animal-level outcomes. A responsible page preserves the encouraging experimental observations without extending them to procedures or conditions that were not studied.

Frequently asked questions

Did treatment begin immediately after surgery?

No, it began two weeks later.

Were established fistulas present?

Yes.

Were later stones reported in the treated groups?

The authors reported no stone formation.

Does that prove existing stones dissolved?

No.

Is a leakage-volume test identical to normal daily bladder function?

No.

Does this establish a human nonsurgical cure?

No.

What requires special numerical review?

The reference and interpretation of the reported leakage-volume comparison.

Information you can check.

Lab reports, store policies, and support — all in one place.

Card options
Visa Mastercard
Available payment options are shown at checkout.
HTTPS connection

For research use only.
Not for human consumption.